Pyxis Oncology names Thomas Civik CEO, chairman
Pyxis Oncology appointed Thomas Civik as permanent chief executive officer and chairman, effective September 4, 2026. John Flavin becomes lead independent director and compensation committee chair.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.